AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous ...
What should the future hold for the House of Lords? A proposed law to legalise assisted dying has stalled in the upper chamber. More than 1,200 amendments were tabled, which is believed to be a record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results